Daily Roundup

Netwealth Group is facing a class action claim related to its First Guardian investment options, with the company's subsidiaries having been served with a Statement of Claim. The litigation connects to issues the company previously addressed through a court-enforceable undertaking with ASIC and a compensation program that wrapped up in January 2026, which saw Netwealth pay approximately $101 million to affected members. The company has signaled its intention to defend the claim vigorously.

Healius Ltd is making a strategic shift by selling its Agilex Biolabs subsidiary to Novotech Health Holdings for A$160 million. The transaction is expected to deliver roughly $155 million in cash proceeds and should complete during the second half of FY 2027, pending standard conditions. The move allows Healius to unlock shareholder value while doubling down on its core Pathology business. Notably, the company doesn't anticipate any tax liability from the deal.

Over at Tamboran Resources, the energy company is celebrating several major milestones from its fourth quarter. The company, alongside joint venture partner Daly Waters Energy, has achieved first gas sales from the Beetaloo Basin into the Northern Territory gas network—a significant breakthrough for the region. Tamboran also wrapped up the largest stimulation program ever conducted in the Beetaloo Basin, which involved three wells and 178 stages. The Sturt Plateau Compression Facility came in on time and roughly US$9 million under budget, while the acquisition of Falcon Oil & Gas was completed in May. With US$240 million in cash and expected near-term inflows on the books, Tamboran is now focused on commissioning, production testing, and hitting its target plateau production of 40 TJ/d.

Microba Life Sciences has appointed Geoffrey Cockerill as Interim Chief Executive Officer following Dr. Luke Reid's medical leave. Cockerill brings more than 30 years of leadership experience, including senior roles at Diageo Australia, Lion, and Subway Systems across Australia, New Zealand, and South-East Asia. He's also previously served as CEO of Vitura Health Limited and ATP Science. His interim appointment runs for an initial six months, extendable by mutual agreement, at a daily rate of $2,100 (excluding GST) for five days per week.

Finally, the iShares S&P 500 ETF has announced an estimated distribution of 17.35 cents per unit. Investors should note the ex-date is 29 September 2026, with the record date on 30 September and payment scheduled for 9 October. The Distribution Reinvestment Plan remains open for those looking to reinvest their payouts.